The 388-patient phase 3 study evaluated uproleselan in combination with MEC (mitoxantrone, etoposide, and cytarabine) or FAI (fludarabine, cytarabine, and idarubicin) in patients with R/R AML.

Moleculin Biotech (MBRX) announced the first patient has been dosed in its Phase 3 pivotal trial evaluating Annamycin in combination with Cytarabine for the treatment of AML patients who are ...

US-based pharmaceutical company Moleculin Biotech has begun dosing subjects in its Phase III MIRACLE trial of Annamycin with cytarabine for treating acute myeloid leukaemia (AML). The trial has ...

Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis.

Venclexta (venetoclax) is already FDA approved in AML in combination with low-dose cytarabine (LDAC) on the basis of early-mid stage trials, but may need confirmatory data from a later stage trial ...

Discover the commercial and brand names of the generic drug Cytarabine. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to understand ...

today announced the first patient has been dosed in its Phase 3 pivotal trial evaluating Annamycin in combination with Cytarabine (also known as “Ara-C” and for which the combination of ...